Contents 1. Executive Summary 2. Antimicrobial Susceptibility Testing Market 2.1. Product Overview 2.2. Market Definition 2.3. Segmentation 2.4. Assumptions and Acronyms 3. Research Methodology 3.1. Research Objectives 3.2. Primary Research 3.3. Secondary Research 3.4. Forecast Model 3.5. Market Size Estimation 4. Average Pricing Analysis 5. Macro-Economic Indicators 6. Market Dynamics 6.1. Growth Drivers 6.2. Restraints 6.3. Opportunity 6.4. Trends 7. Correlation & Regression Analysis 7.1. Correlation Matrix 7.2. Regression Matrix 8. Recent Development, Policies & Regulatory Landscape 9. Risk Analysis 9.1. Demand Risk Analysis 9.2. Supply Risk Analysis 10. Antimicrobial Susceptibility Testing Analysis 10.1. Porters Five Forces 10.1.1. Threat of New Entrants 10.1.2. Bargaining Power of Suppliers 10.1.3. Threat of Substitutes 10.1.4. Rivalry 10.2. PEST Analysis 10.2.1. Political 10.2.2. Economic 10.2.3. Social 10.2.4. Technological 11. Antimicrobial Susceptibility Testing Market 11.1. Market Size & forecast, 2019A-2030F 11.1.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 11.1.2. By Volume (Million Units) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12. Antimicrobial Susceptibility Testing: Market Segmentation 12.1. By Regions 12.1.1. North America: • By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12.1.2. Europe: • By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12.1.3. Asia-Pacific: • By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12.1.4. MEA: • By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12.1.5. Latin America: • By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12.2. By Product: Market Share (2020-2030F) 12.2.1. Manual Antimicrobial Susceptibility Testing Products, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12.2.2. Automated Laboratory Instruments, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12.2.3. Culture and Growth Media, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12.2.4. Consumables, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12.3 By Type: Market Share (2020-2030F) 12.3.1. Antibacterial Testing, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12.3.2. Antifungal Testing, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12.3.3. Antiparasitic Testing, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12.3.4. Others, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12.4. By Application: Market Share (2020-2030F) 12.4.1. Diagnostics, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12.4.2. Drug Discovery and Development, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12.2.3. Epidemiology, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12.4.4. Others, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12.5. By End User: Market Share (2020-2030F) 12.5.1. Hospitals and Diagnostic Centers, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12.5.2. Pharmaceutical and Biotechnology Companies, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12.5.3. Research &Academic Institutes, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12.5.4. Clinical Research Organizations (CROs), By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 13. Company Profile 13.1.1. Bio-Rad Laboratories, Inc 13.1.2. Company Overview 13.1.3. Company Total Revenue (Financials) 13.1.4. Market Potential 13.1.5. Global Presence 13.1.6. Key Performance Indicators 13.1.7. SWOT Analysis 13.1.8. Product Launch 13.2. Alifax 13.3. Becton Dickinson, and Company 13.4. Creative Diagnostics 13.5. Resistell AG 13.6. Danaher Corporation 13.7. Thermo Fisher Scientific Inc 13.8. Merck KGaA 14 Consultant Recommendation **The above given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.